Basis: Operating EBITDA from the trailing two half-years (the two consecutive half-year periods ended 2025-09-30 and 2026-03-31) / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T19:26:01.367Z.
Calculation as of: 2026-10-06T19:26:01.367Z.
Quote observation: 2026-10-06T19:13:34.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c4b29a41b8ab1f3f3a6545c0de7c7b39755195247d73f10f50f83b5ade1155a3
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$2.15M
EBITDA Yield
N/A
TTM Avg
7.59%
3Y Avg
12.54%
5Y Avg
12.54%
Market Cap
$3.80M
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.20M
EBITDA Yield
93.17%
TTM Avg
56.29%
3Y Avg
61.87%
5Y Avg
61.87%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CN Energy Group. Inc. (CNEY) | $1.63M | N/A | N/A | N/A | N/A |
| Capstone Holding Corp. (CAPS)vs › | $2.15M | N/A | 7.59% | 12.54% | 12.54% |
| Stardust Power Inc. (SDST)vs › | $816753.00 | N/A | N/A | N/A | N/A |
| Arcadia Biosciences, Inc. (RKDA)vs › | $453519.00 | N/A | N/A | N/A | N/A |
| Nexentis Technologies Inc. (NXTS)vs › | $79233.00 | N/A | N/A | N/A | N/A |
| J-Star Holding Co., Ltd. Ordinary Shares (YMAT)vs › | $3.80M | N/A | N/A | N/A | N/A |
| ReTo Eco-Solutions, Inc. (RETO)vs › | $3.90M | N/A | N/A | N/A | N/A |
| SenesTech, Inc. (SNES)vs › | $4.18M | N/A | N/A | N/A | N/A |
| Gulf Resources, Inc. (GURE)vs › | $4.20M | 93.17% | 56.29% | 61.87% | 61.87% |
| China Natural Resources, Inc. (CHNR)vs › | $4.87M | N/A | N/A | N/A | N/A |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
